AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,580.00
-10.00 (-0.13%)
Jun 27, 2025, 3:30 PM KST

AptaBio Therapeutics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
203,761171,234201,805237,483
Market Cap Growth
26.74%-15.15%-15.02%-
Enterprise Value
186,805146,945152,862-
Last Close Price
7580.006370.009050.0010650.00
Forward PE
-78.1078.1078.10
PS Ratio
65.5950.95623.114911.46
PB Ratio
3.943.163.294.54
P/TBV Ratio
3.943.163.324.54
EV/Sales Ratio
60.1343.72471.99-
Debt / Equity Ratio
0.150.140.230.01
Asset Turnover
0.040.040.00-
Quick Ratio
1.591.6765.1016.58
Current Ratio
1.791.7970.2719.63
Return on Equity (ROE)
-51.24%-50.84%-21.21%-
Return on Assets (ROA)
-15.63%-15.24%-14.22%-
Return on Capital (ROIC)
-19.16%-18.90%-16.50%-
Earnings Yield
-13.65%-17.16%-5.98%-4.45%
FCF Yield
-8.11%-7.24%-7.65%-3.32%
Buyback Yield / Dilution
-10.78%-5.58%-0.05%-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.